Media Coverage Joni Henderson 9/4/25 Joni Henderson 9/4/25 St. Louis Magazine: C2N’s expansion into former Goodwill building boosts St. Louis’ bioscience startup ecosystem Read More Joni Henderson 8/8/25 Joni Henderson 8/8/25 Patient Care: Novel Plasma Assay That Selectively Detect Tau Characteristics Will Refine Clinical Study of Alzheimer’s Disease Read More Joni Henderson 7/24/25 Joni Henderson 7/24/25 360Dx: C2N Diagnostics Inks Asia Distribution Deal for Alzheimer’s Test with Archerfish Precision Dx Read More Joni Henderson 7/16/25 Joni Henderson 7/16/25 360Dx: C2N Diagnostics: C2N eMTBR-tau243 and C2N %p-tau MAA Tests Read More Joni Henderson 6/24/25 Joni Henderson 6/24/25 PharmaEx.com: The Fight for Alzheimer’s Research Funding Read More Joni Henderson 4/1/25 Joni Henderson 4/1/25 SciTechDaily: New Blood Test Detects Alzheimer’s and Tracks Its Progression With 92% Accuracy Read More Joni Henderson 3/13/25 Joni Henderson 3/13/25 Fierce Biotech: Samsung backs Alzheimer’s blood test developer C2N Diagnostics with $10M Read More Joni Henderson 2/6/25 Joni Henderson 2/6/25 Healio: Blood test may improve decision-making in Alzheimer’s disease Read More Joni Henderson 1/24/25 Joni Henderson 1/24/25 Philanthropy News Digest: MJFF awards $1.5 million to C2N Diagnostics for neurological research Read More Joni Henderson 10/8/24 Joni Henderson 10/8/24 Washington Post: Alzheimer’s patients and their families hear a new word: Progress Read More Joni Henderson 9/26/24 Joni Henderson 9/26/24 Medical Device Network: C2N receives funding for Alzheimer’s disease testing platform Read More Joni Henderson 8/13/24 Joni Henderson 8/13/24 NIH Research Matters: Accurate blood test for Alzheimer’s disease Read More Joni Henderson 8/7/24 Joni Henderson 8/7/24 360Dx: C2N Diagnostics and Unilabs Ink Deal to Sell Precivity Alzheimer’s Dx in Europe, Other Geographies Read More Joni Henderson 7/28/24 Joni Henderson 7/28/24 USA Today: How a new blood test technology could change Alzheimer’s treatment forever Read More Joni Henderson 7/28/24 Joni Henderson 7/28/24 St. Louis Post Dispatch: A St. Louis firm races to diagnose Alzheimer’s faster Read More Joni Henderson 5/2/24 Joni Henderson 5/2/24 The Clinical Trial Vanguard: C2N Diagnostics partners with Mediford for Precivity™ Alzheimer’s Blood Test Expansion in Japan Read More Joni Henderson 3/7/24 Joni Henderson 3/7/24 Fierce Biotech: Eisai to drop up to $15M on C2N Diagnostics to boost the reach of Alzheimer's disease blood tests Read More Joni Henderson 2/23/24 Joni Henderson 2/23/24 Fierce Biotech: Study shows a front-line Alzheimer’s blood test could be as accurate as spinal fluid exams Read More Joni Henderson 2/8/24 Joni Henderson 2/8/24 360Dx: Alzheimer’s Biomarker Research Pushing Plasma P-Tau217 to the Fore Read More Joni Henderson 1/25/24 Joni Henderson 1/25/24 ALZFORUM: AD Blood Tests are Here. Now, Let’s Grapple with How to Use Them Read More Older Posts
Joni Henderson 9/4/25 Joni Henderson 9/4/25 St. Louis Magazine: C2N’s expansion into former Goodwill building boosts St. Louis’ bioscience startup ecosystem Read More
Joni Henderson 8/8/25 Joni Henderson 8/8/25 Patient Care: Novel Plasma Assay That Selectively Detect Tau Characteristics Will Refine Clinical Study of Alzheimer’s Disease Read More
Joni Henderson 7/24/25 Joni Henderson 7/24/25 360Dx: C2N Diagnostics Inks Asia Distribution Deal for Alzheimer’s Test with Archerfish Precision Dx Read More
Joni Henderson 7/16/25 Joni Henderson 7/16/25 360Dx: C2N Diagnostics: C2N eMTBR-tau243 and C2N %p-tau MAA Tests Read More
Joni Henderson 6/24/25 Joni Henderson 6/24/25 PharmaEx.com: The Fight for Alzheimer’s Research Funding Read More
Joni Henderson 4/1/25 Joni Henderson 4/1/25 SciTechDaily: New Blood Test Detects Alzheimer’s and Tracks Its Progression With 92% Accuracy Read More
Joni Henderson 3/13/25 Joni Henderson 3/13/25 Fierce Biotech: Samsung backs Alzheimer’s blood test developer C2N Diagnostics with $10M Read More
Joni Henderson 2/6/25 Joni Henderson 2/6/25 Healio: Blood test may improve decision-making in Alzheimer’s disease Read More
Joni Henderson 1/24/25 Joni Henderson 1/24/25 Philanthropy News Digest: MJFF awards $1.5 million to C2N Diagnostics for neurological research Read More
Joni Henderson 10/8/24 Joni Henderson 10/8/24 Washington Post: Alzheimer’s patients and their families hear a new word: Progress Read More
Joni Henderson 9/26/24 Joni Henderson 9/26/24 Medical Device Network: C2N receives funding for Alzheimer’s disease testing platform Read More
Joni Henderson 8/13/24 Joni Henderson 8/13/24 NIH Research Matters: Accurate blood test for Alzheimer’s disease Read More
Joni Henderson 8/7/24 Joni Henderson 8/7/24 360Dx: C2N Diagnostics and Unilabs Ink Deal to Sell Precivity Alzheimer’s Dx in Europe, Other Geographies Read More
Joni Henderson 7/28/24 Joni Henderson 7/28/24 USA Today: How a new blood test technology could change Alzheimer’s treatment forever Read More
Joni Henderson 7/28/24 Joni Henderson 7/28/24 St. Louis Post Dispatch: A St. Louis firm races to diagnose Alzheimer’s faster Read More
Joni Henderson 5/2/24 Joni Henderson 5/2/24 The Clinical Trial Vanguard: C2N Diagnostics partners with Mediford for Precivity™ Alzheimer’s Blood Test Expansion in Japan Read More
Joni Henderson 3/7/24 Joni Henderson 3/7/24 Fierce Biotech: Eisai to drop up to $15M on C2N Diagnostics to boost the reach of Alzheimer's disease blood tests Read More
Joni Henderson 2/23/24 Joni Henderson 2/23/24 Fierce Biotech: Study shows a front-line Alzheimer’s blood test could be as accurate as spinal fluid exams Read More
Joni Henderson 2/8/24 Joni Henderson 2/8/24 360Dx: Alzheimer’s Biomarker Research Pushing Plasma P-Tau217 to the Fore Read More
Joni Henderson 1/25/24 Joni Henderson 1/25/24 ALZFORUM: AD Blood Tests are Here. Now, Let’s Grapple with How to Use Them Read More
